Your browser doesn't support javascript.
loading
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Deng, Maximilian Y; Sill, Martin; Chiang, Jason; Schittenhelm, Jens; Ebinger, Martin; Schuhmann, Martin U; Monoranu, Camelia-Maria; Milde, Till; Wittmann, Andrea; Hartmann, Christian; Sommer, Clemens; Paulus, Werner; Gärtner, Jutta; Brück, Wolfgang; Rüdiger, Thomas; Leipold, Alfred; Jaunmuktane, Zane; Brandner, Sebastian; Giangaspero, Felice; Nozza, Paolo; Mora, Jaume; Morales la Madrid, Andres; Cruz Martinez, Ofelia; Hansford, Jordan R; Pietsch, Torsten; Tietze, Anna; Hernáiz-Driever, Pablo; Stoler, Iris; Capper, David; Korshunov, Andrey; Ellison, David W; von Deimling, Andreas; Pfister, Stefan M; Sahm, Felix; Jones, David T W.
Afiliação
  • Deng MY; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
  • Sill M; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Chiang J; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
  • Schittenhelm J; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Ebinger M; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Schuhmann MU; Department of Neuropathology, Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital of Tübingen, Tübingen, Germany.
  • Monoranu CM; Department of Pediatric Hematology/Oncology, Children's University Hospital, Tübingen, Germany.
  • Milde T; Division of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
  • Wittmann A; Department of Neuropathology, Institute of Pathology, University of Würzburg, Comprehensive Cancer Center (CCC) Mainfranken, Würzburg, Germany.
  • Hartmann C; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
  • Sommer C; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), 69120, Heidelberg, Germany.
  • Paulus W; Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, 69120, Heidelberg, Germany.
  • Gärtner J; KiTZ Clinical Trial Unit (ZIPO), 69120, Heidelberg, Germany.
  • Brück W; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
  • Rüdiger T; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Leipold A; Department of Neuropathology, Hannover Medical School, Hannover, Germany.
  • Jaunmuktane Z; Institute of Neuropathology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Brandner S; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
  • Giangaspero F; Division of Pediatric Neurology, Department of Pediatrics and Adolescent Medicine, University of Göttingen Medical Center, Göttingen, Germany.
  • Nozza P; Department of Neuropathology, University of Göttingen Medical Center, Göttingen, Germany.
  • Mora J; Institute of Pathology, Klinikum Karlsruhe, Karlsruhe, Germany.
  • Morales la Madrid A; Department of Pediatrics, Klinikum Karlsruhe, Karlsruhe, Germany.
  • Cruz Martinez O; Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, UK.
  • Hansford JR; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
  • Pietsch T; Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, UK.
  • Tietze A; Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
  • Hernáiz-Driever P; IRCCS Neuromed, Pozzilli, Italy.
  • Stoler I; Department of Radiological, Oncological and Anatomo-pathological Science, Sapienza University of Rome, Rome, Italy.
  • Capper D; Pathology Unit, Istituto Giannina Gaslini, Genoa, Italy.
  • Korshunov A; Department of Pediatric Hemato-Oncology, Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain.
  • Ellison DW; Department of Pediatric Hemato-Oncology, Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain.
  • von Deimling A; Department of Pediatric Hemato-Oncology, Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain.
  • Pfister SM; Department of Paediatrics, Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia.
  • Sahm F; Institute of Neuropathology, Brain Tumor Reference Center of the Society for Neuropathology and Neuroanatomy, University of Bonn Medical Center, Bonn, Germany.
  • Jones DTW; Institute of Neuroradiology, Charité Universitätsmedizin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Acta Neuropathol ; 136(2): 239-253, 2018 08.
Article em En | MEDLINE | ID: mdl-29766299

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Neoplasias Meníngeas Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Neoplasias Meníngeas Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha